|
Intellectual property and medicine
|
| Section A: Intellectual property
of medicine and its sources |
| ·
Categories of intellectual property relevant to medicine
|
| ·
International framework and history of intellectual property
relevant to medicine |
| ·
Categories of intellectual property relevant to medicine
|
| ·
European and National systems (UK and designated
jurisdictions) |
| ·
Applications of intellectual property in medical and
pharmaceutical industries |
| Section B: Access to medicines
|
| ·
Overview of the issues and history of the campaign
|
| ·
Human right to health and the ethics of patents |
| ·
TRIPS Agreement |
| ·
Doha Development Round (Ministerial Declaration; Declaration
on TRIPS and Public Health; Decision on Paragraph 6)
|
| ·
Paragraph 6 System |
| Section C: Patents and life forms
|
| ·
Legal and socio-legal concept of life form |
| ·
Ethical considerations and exceptions |
| ·
Medical biotechnologies |
| ·
International, European and designated domestic frameworks
(including European Biotechnology Directive) |
| ·
Genes and gene sequences |
| ·
Cloning |
| ·
Germ-line modification technology |
| ·
Embryos |
| Section D: Property in the person
|
| ·
Medical and genetic privacy and intellectual property
|
| ·
Genetic privacy |
| ·
Genetic sampling and collection; genomic libraries and
databases |
| ·
Traditional medicine and genetic resources |
Sequence:
The sections must be
attempted in order.
|
Textbook:
Johanna Gibson, Intellectual Property and Medicine:
Current Debates (London: Ashgate,2009), ISBN:
0754672182 |
